# BONE BIOLOGICS CORP (BBLGW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BBLGW/

- Reporting holders: 2
- Reported value: $796.0K
- Shares held by institutions: 53,309 of 2,756,057 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $791.9K | 52,796 | 0.0% | 10 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $4.1K | 513 | 0.0% | 8 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 2 | $796.0K |
| Q1 2026 | 2 | $689.9K |
| Q4 2025 | 2 | $550.5K |
| Q3 2025 | 3 | $357.7K |
| Q2 2025 | 3 | $537.0K |
| Q1 2025 | 3 | $557.3K |
| Q4 2024 | 2 | $1.5M |
| Q3 2024 | 2 | $1.8M |
| Q2 2024 | 2 | $2.0M |
| Q1 2024 | 3 | $570.4K |
| Q4 2023 | 1 | $44.9K |
| Q3 2023 | 3 | $324.4K |